To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Generate Biomedicines by 15,098 shares, the number of shares held increased 3.27% compared to the previous period and now represents 0.5% of the total position.
      315Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Natera by 2,853 shares, the number of shares held increased 1.18% compared to the previous period and now represents 4.17% of the total position.
      93Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Nurix Therapeutics by 18,756 shares, the number of shares held increased 1.19% compared to the previous period and now represents 2.07% of the total position.
      124Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 12,321 shares, the number of shares held increased 106.67% compared to the previous period and now represents 2% of the total position.
      1071
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 53,199 shares, the number of shares held increased 1.19% compared to the previous period and now represents 1.96% of the total position.
      3051
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 118,548 shares, the number of shares held increased 1.19% compared to the previous period and now represents 1.02% of the total position.
      13.83K3
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 53,604 shares, the number of shares held increased 1.19% compared to the previous period and now represents 1.09% of the total position.
      16Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Veracyte by 10,440 shares, the number of shares held increased 1.19% compared to the previous period and now represents 3.45% of the total position.
      18Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 3,132 shares, the number of shares held increased 1.18% compared to the previous period and now represents 1.5% of the total position.
      10Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-20
      ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 36,081 shares, the number of shares held increased 1.19% compared to the previous period and now represents 2.77% of the total position.
      114Comment
      Report
       
       
       
       

      Most Discussed